HRC Is a Direct Transcriptional Target of MEF2 during Cardiac, Skeletal, and Arterial Smooth Muscle Development In Vivo

Molecular and Cellular Biology

Volumn 24, Issue 9, 2004, Pages 3757-3768

  Anderson, Joshua P ^a   Dodou, Evdokia ^a   Heidt, Analeah B ^a   De Val, Sarah J ^a   Jaehnig, Eric J ^a   Greene, Stephanie B ^a   Olson, Eric N ^b   Black, Brian L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CALCIUM BINDING PROTEIN; HISTIDINE; MYOCYTE ENHANCER FACTOR 2; SERUM RESPONSE FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; BINDING SITE; CELL TYPE; CONTROLLED STUDY; EMBRYO; ENHANCER REGION; GENE; GENE FUNCTION; GENE TARGETING; HEART MUSCLE CELL; HRC GENE; HUMAN; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

AMINO ACID MOTIFS; ANIMALS; BASE SEQUENCE; CALCIUM-BINDING PROTEINS; DNA-BINDING PROTEINS; EMBRYO; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, REPORTER; HEART; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCLE, SMOOTH, VASCULAR; MYOGENIC REGULATORY FACTORS; PROMOTER REGIONS (GENETICS); SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA; MUS MUSCULUS;

EID: 1942453894     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.9.3757-3768.2004     Document Type: Article

References (60)

1. Andres, V., M. Cervera, and V. Mahdavi. 1995. Determination of the consensus binding site for MEF2 expressed in muscle and brain reveals tissue-specific sequence constraints. J. Biol. Chem. 270:23246-23249.
2. 2+-ATPase (SERCA2) gene. Nucleic Acids Res. 26:1092-1098.
3. 2+-ATPase gene promoter are required for expression in Sol8 muscle cells. J. Biol. Chem. 271:5921-5928.
4. Bi, W., C. J. Drake, and J. J. Schwarz. 1999. The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF. Dev. Biol. 211:255-267.
5. Black, B. L., J. Lu, and E. N. Olson. 1997. The MEF2A 3′ untranslated region functions as a cis-acting translational repressor. Mol. Cell. Biol. 17:2756-2763.
6. Black, B. L., J. F. Martin, and E. N. Olson. 1995. The mouse MRF4 promoter is trans-activated directly and indirectly by muscle-specific transcription factors. J. Biol. Chem. 270:2889-2892.
7. Black, B. L., J. D. Molkentin, and E. N. Olson. 1998. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Mol. Cell. Biol. 18:69-77.
8. Black, B. L., and E. N. Olson. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167-196.
9. Bour, B. A., M. A. O'Brien, W. L. Lockwood, E. S. Goldstein, R. Bodmer, P. H. Taghert, S. M. Abmayr, and H. T. Nguyen. 1995. Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev. 9:730-741.
10. Chang, D. F., N. S. Belaguli, D. Iyer, W. B. Roberts, S. P. Wu, X. R. Dong, J. G. Marx, M. S. Moore, M. C. Beckerle, M. W. Majesky, and R. J. Schwartz. 2003. Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev. Cell 4:107-118.
11. Chang, P. S., L. Li, J. McAnally, and E. N. Olson. 2001. Muscle specificity encoded by specific serum response factor-binding sites. J. Biol. Chem. 276:17206-17212.
12. Chang, Y. F., J. Wei, X. Liu, Y. H. Chen, M. D. Layne, and S. F. Yet. 2003. Identification of a CArG-independent region of the cysteine-rich protein 2 promoter that directs expression in the developing vasculature. Am. J. Physiol. Heart Circ. Physiol. 285:H1675-H1683.
13. Cheng, T. C., M. C. Wallace, J. P. Merlie, and E. N. Olson. 1993. Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science 261:215-218.
14. Cripps, R. M., B. L. Black, B. Zhao, C. L. Lien, R. A. Schulz, and E. N. Olson. 1998. The myogenic regulatory gene Mef2 is a direct target for transcriptional activation by Twist during Drosophila myogenesis. Genes Dev. 12:422-434.
15. 2+- and low-density-lipoprotein-binding protein in rabbit skeletal muscle. Biochem. J. 277:825-832.
16. Dodou, E., S. M. Xu, and B. L. Black. 2003. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo. Mech. Dev. 120:1021-1032.
17. Edmondson, D. G., T. C. Cheng, P. Cserjesi, T. Chakraborty, and E. N. Olson. 1992. Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol. Cell. Biol. 12:3665-3677.
18. Firulli, A. B., J. M. Miano, W. Bi, A. D. Johnson, W. Casscells, E. N. Olson, and J. J. Schwarz. 1996. Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells. Association with the activated phenotype. Circ. Res. 78:196-204.
19. Frank, K. F., L. Mesnard-Rouiller, G. Chu, K. B. Young, W. Zhao, K. Haghighi, Y. Sato, and E. G. Kranias. 2001. Structure and expression of the mouse cardiac calsequestrin gene. Basic Res. Cardiol. 96:636-644.
20. 2+ and plasma lipoproteins. J. Biol. Chem. 264:8260-8270.
21. 2+-binding protein of sarcoplasmic reticulum that contains highly conserved repeated elements. J. Biol. Chem. 264:18083-18090.
22. Hofmann, S. L., M. Topham, C. L. Hsieh, and U. Francke. 1991. cDNA and genomic cloning of HRC, a human sarcoplasmic reticulum protein, and localization of the gene to human chromosome 19 and mouse chromosome 7. Genomics 9:656-669.
23. Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the mouse embryo, 2nd ed. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
24. Horton, R. M. 1997. In vitro recombination and mutagenesis of DNA: SOEing together tailor-made genes, p. 141-149. In B. A. White (ed.), PCR cloning protocols, vol. 67. Humana Press, Totowa, N.J.
25. 2+ binding protein). Biochem. Biophys. Res. Commun. 300:192-196.
26. Kim, S., H. S. Ip, M. M. Lu, C. Clendenin, and M. S. Parmacek. 1997. A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Mol. Cell. Biol. 17:2266-2278.
27. Kothary, R., S. Clapoff, S. Darling, M. D. Perry, L. A. Moran, and J. Rossant. 1989. Inducible expression of an hsp68-lacZ hybrid gene in transgenic mice. Development 105:707-714.
28. Layne, M. D., S. F. Yet, K. Maemura, C. M. Hsieh, X. Liu, B. Ith, M. E. Lee, and M. A. Perrella. 2002. Characterization of the mouse aortic carboxypeptidase-like protein promoter reveals activity in differentiated and dedifferentiated vascular smooth muscle cells. Circ. Res. 90:728-736.
29. 2+-binding protein) and triadin in the lumen of sarcoplasmic reticulum. J. Biol. Chem. 276:39533-39538.
30. Li, L., Z. Liu, B. Mercer, P. Overbeek, and E. N. Olson. 1997. Evidence for serum response factor-mediated regulatory networks governing SM22α transcription in smooth, skeletal, and cardiac muscle cells. Dev. Biol. 187:311-321.
31. Li, L., J. M. Miano, B. Mercer, and E. N. Olson. 1996. Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J. Cell Biol. 132:849-859.
32. Lilly, B., E. N. Olson, and M. C. Beckerle. 2001. Identification of a CArG box-dependent enhancer within the cysteine-rich protein 1 gene that directs expression in arterial but not venous or visceral smooth muscle cells. Dev. Biol. 240:531-547.
33. Lilly, B., B. Zhao, G. Ranganayakulu, B. M. Paterson, R. A. Schulz, and E. N. Olson. 1995. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science 267:688-693.
34. Lin, Q., J. Lu, H. Yanagisawa, R. Webb, G. E. Lyons, J. A. Richardson, and E. N. Olson. 1998. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125:4565-4574.
35. Lin, Q., J. Schwarz, C. Bucana, and E. N. Olson. 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404-1407.
36. Lu, J., T. A. McKinsey, C. L. Zhang, and E. N. Olson. 2000. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6:233-244.
37. Mack, C. P., and G. K. Owens. 1999. Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5′ and first intron promoter regions. Circ. Res. 84:852-861.
38. Mack, C. P., M. M. Thompson, S. Lawrenz-Smith, and G. K. Owens. 2000. Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ. Res. 86:221-232.
39. Manabe, I., and G. K. Owens. 2001. CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J. Clin. Investig. 107:823-834.
40. McFadden, D. G., J. Charite, J. A. Richardson, D. Srivastava, A. B. Firulli, and E. N. Olson. 2000. A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart. Development 127:5331-5341.
41. McKinsey, T. A., C. L. Zhang, J. Lu, and E. N. Olson. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408:106-111.
42. McKinsey, T. A., C. L. Zhang, and E. N. Olson. 2001. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11:497-504.
43. McTiernan, C. F., C. S. Frye, B. H. Lemster, E. A. Kinder, M. L. Ogletree-Hughes, C. S. Moravec, and A. M. Feldman. 1999. The human phospholamban gene: structure and expression. J. Mol. Cell. Cardiol. 31:679-692.
44. Mericskay, M., A. Parlakian, A. Porteu, F. Dandre, J. Bonnet, D. Paulin, and Z. Li. 2000. An overlapping CArG/octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells. Dev. Biol. 226:192-208.
45. Molkentin, J. D., B. L. Black, J. F. Martin, and E. N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125-1136.
46. Morin, S., F. Charron, L. Robitaille, and M. Nemer. 2000. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 19:2046-2055.
47. Naya, F. J., C. Wu, J. A. Richardson, P. Overbeek, and E. N. Olson. 1999. Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development 126:2045-2052.
48. 2+-release channel gene of cardiac sarcoplasmic reticulum. Eur. J. Biochem. 240:408-415.
49. Ornatsky, O. I., J. J. Andreucci, and J. C. McDermott. 1997. A dominant-negative form of transcription factor MEF2 inhibits myogenesis. J. Biol. Chem. 272:33271-33278.
50. Parmacek, M. S. 2001. Transcriptional programs regulating vascular smooth muscle cell development and differentiation. Curr. Top. Dev. Biol. 51:69-89.
51. Pathak, R. K., R. G. Anderson, and S. L. Hofmann. 1992. Histidine-rich calcium binding protein, a sarcoplasmic reticulum protein of striated muscle, is also abundant in arteriolar smooth muscle cells. J. Muscle Res. Cell Motil. 13:366-376.
52. 2+-binding protein of skeletal muscle sarcoplasmic reticulum. Biochem. Biophys. Res. Commun. 186:659-667.
53. Ranganayakulu, G., B. Zhao, A. Dokidis, J. D. Molkentin, E. N. Olson, and R. A. Schulz. 1995. A series of mutations in the D-MEF2 transcription factor reveal multiple functions in larval and adult myogenesis in Drosophila. Dev. Biol. 171:169-181.
54. Schmoelzl, S., T. Leeb, H. Brinkmeier, G. Brem, and B. Brenig. 1996. Regulation of tissue-specific expression of the skeletal muscle ryanodine receptor gene. J. Biol. Chem. 271:4763-4769.
55. 2+ binding protein) resides in the lumen of sarcoplasmic reticulum as a multimer. Biochem. Biophys. Res. Commun. 263:667-671.
56. Verzi, M. P., J. P. Anderson, E. Dodou, K. K. Kelly, S. B. Greene, B. J. North, R. M. Cripps, and B. L. Black. 2002. N-twist, an evolutionarily conserved bHLH protein expressed in the developing CNS, functions as a transcriptional inhibitor. Dev. Biol. 249:174-190.
57. Wang, D. Z., S. Li, D. Hockemeyer, L. Sutherland, Z. Wang, G. Schratt, J. A. Richardson, A. Nordheim, and E. N. Olson. 2002. Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc. Natl. Acad. Sci. USA 99:14855-14860.
58. Wang, Z., D. Z. Wang, G. C. Pipes, and E. N. Olson. 2003. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl. Acad. Sci. USA 100:7129-7134.
59. Yee, S. P., and P. W. Rigby. 1993. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev. 7:1277-1289.
60. Yoshida, T., S. Sinha, F. Dandre, B. R. Wamhoff, M. H. Hoofnagle, B. E. Kremer, D. Z. Wang, E. N. Olson, and G. K. Owens. 2003. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ. Res. 92:856-864.